​

Krystal Biotech Ownership | Who Owns Krystal Biotech?

OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary

Krystal Biotech is owned by 55.61% institutional investors, 11.73% insiders, and 32.66% retail investors. Fmr is the largest institutional shareholder, holding 15.11% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.14% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKrystal Biotech55.61%11.73%32.66%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.37M15.11%$1.13B
Blackrock3.95M13.95%$724.98M
Blackrock funding, inc. /de3.94M13.61%$1.02B
Avoro capital advisors2.89M9.98%$746.26M
Vanguard group2.78M9.60%$685.10M
State street1.31M4.54%$339.54M
Soleus capital management1.15M3.98%$297.87M
Capital world investors824.72K2.85%$213.04M
Redmile group673.50K2.33%$173.98M
Geode capital management643.98K2.22%$166.38M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Act capital management60.48K12.28%$15.62M
Soleus capital management1.15M12.06%$297.87M
Redmile group673.50K11.52%$173.98M
S squared86.22K8.43%$22.27M
Avoro capital advisors2.89M7.34%$746.26M
Evolutionary tree capital management16.81K4.81%$4.14M
Palisades investment partners45.41K4.60%$11.73M
Frazier life sciences management481.31K3.20%$124.33M
Bellevue group481.79K2.96%$124.45M
Biondo investment advisors72.05K2.39%$18.61M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Norges bank284.57K0.01%284.57K
Soleus capital management1.15M12.06%212.03K
Invesco251.37K0.01%191.37K
Vanguard fiduciary trust179.16K0.01%179.16K

Top Sellers

HolderShares% AssetsChange
Citadel advisors2.73K0.00%-383.78K
T. rowe price investment management---185.55K
Baker bros. advisors lp---169.93K
Lord, abbett---151.22K
Driehaus capital management---121.70K

New Positions

HolderShares% AssetsChangeValue
Norges bank284.57K0.01%284.57K$70.16M
Vanguard fiduciary trust179.16K0.01%179.16K$46.28M
Eagle asset management76.26K0.07%76.26K$13.90M
Gilder gagnon howe40.13K0.12%40.13K$10.37M
Vanguard asset management20.61K0.00%20.61K$5.32M

Sold Out

HolderChange
Tfc financial management-1.00
Optiver b.v.-1.00
Tradewinds capital management-1.00
Rakuten securities-1.00
Tortoise investment management-1.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025232-22.15%16,100,358-42.52%550.59%128-16.88%74-12.94%
Sep 30, 20252894.33%27,787,3363.78%961.12%1497.19%83-10.75%
Jun 30, 2025280-10.26%27,626,5581.12%951.06%140-8.50%94-16.07%
Mar 31, 20253109.54%27,310,084-1.64%941.01%15213.43%11112.12%
Dec 31, 2024175-41.28%17,639,222-37.00%610.65%85-45.51%63-31.52%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology1.81M6.14%-
iShares Core S&P Small-Cap ETF1.57M5.33%327.00
Fidelity Growth Compy Commingled Pl S1.05M3.56%5.40K
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Vanguard Total Stock Mkt Idx Inv830.91K2.82%4.46K
Fidelity Growth Company Fund785.52K2.67%10.00K
American Funds SMALLCAP World A752.24K2.56%-
Vanguard Small Cap Index607.37K2.06%14.64K
iShares Russell 2000 ETF583.03K1.98%4.93K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 04, 2026Krishnan Suma President, R&DSell$954.76K
Mar 04, 2026Krishnan Suma President, R&DSell$104.73K
Mar 04, 2026Krishnan Suma President, R&DSell$173.42K
Mar 04, 2026Krishnan Suma President, R&DSell$152.28K
Mar 04, 2026Krishnan Suma President, R&DSell$766.20K

Insider Transactions Trends

DateBuySell
2026 Q1-52
2025 Q4-32
2025 Q3-30
2025 Q2--
2025 Q1-21

KRYS Ownership FAQ

Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 55.61%, followed by 11.73% insiders and 32.66% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 379.48%, which Krystal Biotech falls below.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.37M shares, 15.11%), Blackrock (3.95M shares, 13.95%), and Blackrock funding, inc. /de (3.94M shares, 13.61%). Together, they hold 42.68% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Act capital management is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 12.28% of its assets in 60.48K Krystal Biotech shares, valued at 15.62M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.14% of its total shares outstanding invested in 1.81M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools